Condensed Consolidated Statements of Operations and Comprehensive Loss - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023
Income Statement [Abstract]
Net revenue	$ 16,370	$ 12,582	$ 27,254	$ 23,164
Operating costs and expenses:
Cost of revenue	4,390	4,177	8,230	7,768
Research and development	2,004	3,204	5,112	5,940
Selling, general and administrative	24,598	26,989	53,876	55,690
Intangible amortization	1,001	1,026	2,028	2,053
Legal settlements	0	0	(6,891)	0
Total operating costs and expenses	31,993	35,396	62,355	71,451
Loss from operations	(15,623)	(22,814)	(35,101)	(48,287)
Other expense:
Loss on derivative liability	15,284	82	15,741	5,335
Change in fair value of debt and liability instruments	6,099	3,748	10,004	3,748
Interest expense, net	571	5	1,102	4
Loss on foreign currency exchange	5	3	11	23
Total other expense	21,959	3,838	26,858	9,110
Loss before income taxes	(37,582)	(26,652)	(61,959)	(57,397)
Income tax expense (benefit)	0	(3)	0	5
Net loss	$ (37,582)	$ (26,649)	$ (61,959)	$ (57,402)
Earnings Per Share [Abstract]
Net loss per share attributable to common stockholders - basic	$ (0.31)	$ (0.19)	$ (0.56)	$ (0.4)
Net loss per share attributable to common stockholders - diluted	$ (0.31)	$ (0.19)	$ (0.56)	$ (0.4)
Weighted Average Number of Shares Outstanding, Diluted [Abstract]
Weighted average number of shares during the period-basic	120,188	142,626	111,449	142,146
Weighted average number of shares during the period -diluted	120,188	142,626	111,449	142,146
Comprehensive loss:
Net Income (Loss)	$ (37,582)	$ (26,649)	$ (61,959)	$ (57,402)
Other comprehensive income:
Changes in fair value attributable to instrument-specific credit risk	1,851	0	1,851	0
Total other comprehensive income	1,851	0	1,851	0
Comprehensive loss	$ (35,731)	$ (26,649)	$ (60,108)	$ (57,402)